$377 A soothing IV designed to rehydrate, reduce fever, and support recovery from viral illness
Weight regain after stopping semaglutide or any other GLP-1 receptor agonist is a very common side effect
The flexible linker ensures spatial separation between the Fc region and the GLP-1 receptorbinding domain, preserving receptor accessibility and bioactivity

CrossRef Hepatic inflammation after exposure to a mixture of low-dose arsenic and cadmium in a murine model of fatty liver disease Nivetha K Subramaniam, Natascha Gagnon, Cynthia Guilbert, Rushmi Perinpanathan, Madelyn Abraham, Christophe Goncalves, Jaymie R Meliker, Sonia Del Rincon, Koren K Mann Toxicological Sciences .2026;[Epub] CrossRef Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model Parisa Taheri, Fatemeh Majidi, Kosar Nouri, Masoumeh Nouri, Morteza Zarrabi, Elham Rismani, Abbas Piryaei, Massoud Vosough In vitro models .2026;[Epub] CrossRef DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4 and PPAR Hyun Ahm Sohn, Hanyong Go, Tae Hyeon An, Jun Min Lee, Hee-Jin Kim, Keeok Haam, Amal Magdy, Hyo-Jung Jung, Yang-Ji Shin, Hyun Jung Lim, Yujin Jeong, Yejin Bae, Youngae Jung, Seong-Hwan Park, Kyung Chan Park, Myeong Jun Song, Eun-Wie Cho, Eun-Soo Kwon, Jeon Clinical and Molecular Hepatology .2026

GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects